IDEAS home Printed from https://ideas.repec.org/a/eee/socmed/v131y2015icp289-296.html
   My bibliography  Save this article

Patient involvement in drug licensing: A case study

Author

Listed:
  • Britten, Nicky
  • Denford, Sarah
  • Harris-Golesworthy, Faith
  • Jibson, Steph
  • Pyart, Nigel
  • Stein, Ken

Abstract

Embodied health movements work on the boundary between lay and expert knowledge. Consumer groups, depending on their goals, may increase or decrease pharmaceuticalization. This paper reports a small case study about the retrospective evaluation of a specific second line treatment for type 2 diabetes by an existing patient involvement group. The group is part of a research collaboration between academia and the health service in England, and shares some characteristics of embodied health movements. We used the case study to explore whether an institutionally funded non activist patient group can make a more balanced contribution to drug licensing decisions than that made by either access-oriented or injury-oriented consumer groups, without being co-opted by an institutional agenda. The questions we wished to address were how this group evaluated existing mechanisms for licensing drugs; how they balanced scientific and lay knowledge; how they made their decisions; and how they viewed their experiences as panel members. The five panel members were interviewed before and after the panel discussion in July 2013. They were critical of current licensing processes, and used their own embodied experiences of medicines to evaluate expert knowledge. Their decisions on the panel were informed either by a balancing of benefits and harms, or by trust in experts. The case study suggests that such a group may have the potential both to balance the pro-pharmaceuticalization impact of access-oriented groups and to influence forms of pharmaceutical governance.

Suggested Citation

  • Britten, Nicky & Denford, Sarah & Harris-Golesworthy, Faith & Jibson, Steph & Pyart, Nigel & Stein, Ken, 2015. "Patient involvement in drug licensing: A case study," Social Science & Medicine, Elsevier, vol. 131(C), pages 289-296.
    • Handle: RePEc:eee:socmed:v:131:y:2015:i:c:p:289-296
    DOI: 10.1016/j.socscimed.2014.10.024
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0277953614006704
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.socscimed.2014.10.024?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Hemminki, Elina & Toiviainen, Hanna K. & Vuorenkoski, Lauri, 2010. "Co-operation between patient organisations and the drug industry in Finland," Social Science & Medicine, Elsevier, vol. 70(8), pages 1171-1175, April.
    2. Barbot, Janine, 2006. "How to build an "active" patient? The work of AIDS associations in France," Social Science & Medicine, Elsevier, vol. 62(3), pages 538-551, February.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Baggott, Rob & Jones, Kathryn, 2014. "The voluntary sector and health policy: The role of national level health consumer and patients' organisations in the UK," Social Science & Medicine, Elsevier, vol. 123(C), pages 202-209.
    2. Kempner, Joanna & Bailey, John, 2019. "Collective self-experimentation in patient-led research: How online health communities foster innovation," Social Science & Medicine, Elsevier, vol. 238(C), pages 1-1.
    3. Shai Mulinari & Andreas Vilhelmsson & Emily Rickard & Piotr Ozieranski, 2020. "Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs," PLOS ONE, Public Library of Science, vol. 15(6), pages 1-19, June.
    4. Vololona Rabeharisoa, 2013. "Evidence-based activism: Patients’ organisations, users’ and activist’s groups in knowledge society," CSI Working Papers Series 033, Centre de Sociologie de l'Innovation (CSI), Mines ParisTech.
    5. Mulinari, Shai & Pashley, Dylan & Ozieranski, Piotr, 2022. "Advancing international comparison of pharmaceutical industry funding of patient advocacy: Focus on Denmark," Health Policy, Elsevier, vol. 126(12), pages 1256-1262.
    6. Watkins-Hayes, Celeste & Pittman-Gay, LaShawnDa & Beaman, Jean, 2012. "‘Dying from’ to ‘living with’: Framing institutions and the coping processes of African American women living with HIV/AIDS," Social Science & Medicine, Elsevier, vol. 74(12), pages 2028-2036.
    7. Rickard, Emily & Ozieranski, Piotr & Mulinari, Shai, 2019. "Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK," Health Policy, Elsevier, vol. 123(12), pages 1244-1250.
    8. Cinzia Colombo & Paola Mosconi & Walter Villani & Silvio Garattini, 2012. "Patient Organizations’ Funding from Pharmaceutical Companies: Is Disclosure Clear, Complete and Accessible to the Public? An Italian Survey," PLOS ONE, Public Library of Science, vol. 7(5), pages 1-8, May.
    9. Madeleine Akrich & Maire Leane & Celia Roberts & João Arriscado Nunes, 2012. "Practising childbirth activism: a politics of evidence," CSI Working Papers Series 023, Centre de Sociologie de l'Innovation (CSI), Mines ParisTech.
    10. Barbot, Janine & Parizot, Isabelle & Winance, Myriam, 2014. "“No-fault” compensation for victims of medical injuries. Ten years of implementing the French model," Health Policy, Elsevier, vol. 114(2), pages 236-245.
    11. Susanna Priolo & Andras Fehervary & Phil Riggins & Kathy Redmond, 2012. "Assessing Stakeholder Opinion on Relations between Cancer Patient Groups and Pharmaceutical Companies in Europe," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 5(2), pages 127-139, June.
    12. Fillion, Emmanuelle, 2008. "Clinical relationships tested by iatrogenicity: The case of haemophiliac patients faced with the epidemic of transfusional AIDS," Social Science & Medicine, Elsevier, vol. 67(9), pages 1400-1409, November.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:socmed:v:131:y:2015:i:c:p:289-296. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/wps/find/journaldescription.cws_home/315/description#description .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.